Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma

Nitecki, 1995, Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?, Ann Surg, 221, 59, 10.1097/00000658-199501000-00007 Willett, 1993, Resection margins in carcinoma of the head of the pancreas: Implications for radiation therapy, Ann Surg, 217, 144, 10.1097/00000658-199302000-00008 Klinkenbijl, 1999, Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group, Ann Surg, 230, 776, 10.1097/00000658-199912000-00006 1987, Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer, Cancer, 59, 2006, 10.1002/1097-0142(19870615)59:12<2006::AID-CNCR2820591206>3.0.CO;2-B Neoptolemos, 2004, A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer, N Engl J Med, 350, 1200, 10.1056/NEJMoa032295 Willett, 2005, Locally advanced pancreatic cancer, J Clin Oncol, 23, 4538, 10.1200/JCO.2005.23.911 Regine, 2008, Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial, JAMA, 299, 1019, 10.1001/jama.299.9.1019 Chauffert, 2008, Ann Oncol, 19, 1592, 10.1093/annonc/mdn281 Ben-Josef, 2004, Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer, Int J Radiat Oncol Biol Phys, 59, 454, 10.1016/j.ijrobp.2003.11.019 Brown, 2006, A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma, Int J Radiat Oncol Biol Phys, 65, 274, 10.1016/j.ijrobp.2006.01.003 Milano, 2004, Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: Toxicity and clinical outcome, Int J Radiat Oncol Biol Phys, 59, 445, 10.1016/j.ijrobp.2003.11.003 Yovino, 2011, Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary cancers, Int J Radiat Oncol Biol Phys, 79, 158, 10.1016/j.ijrobp.2009.10.043 Koong, 2005, Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 63, 320, 10.1016/j.ijrobp.2005.07.002 Abrams, 2011, Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704-A phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas, Int J Radiat Oncol Biol Phys Van Laethem, 2010, Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: A randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study, J Clin Oncol, 28, 4450, 10.1200/JCO.2010.30.3446 Stocken, 2005, Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer, Br J Cancer, 92, 1372, 10.1038/sj.bjc.6602513 Abrams R, Regine WF, Goodman KA, et al. Consensus panel contouring atlas for the delineation of the clinical target volume in the postoperative treatment of pancreatic cancer [RTOG Web site]. April 16, 2010. Available from: http://www.rtog.org/CoreLab/ContouringAtlases/PancreasAtlas.aspx. Accessed April 21, 2011.